MARZ VFX and Vitamin VFX, two leading visual effects companies, have announced their merger to form a new global excellence partnership. The merger brings together the expertise and resources of both companies to create a powerhouse in the world of visual effects.
The newly formed partnership, known as MARZ VFX, will be headquartered in Toronto, Canada, with offices in Los Angeles, Montreal, and Vancouver. The merger will allow MARZ VFX to offer a wider range of services to clients around the world, including visual effects, animation, virtual reality, and augmented reality.
One of the most exciting developments to come out of the merger is the launch of MARZ AI, a cutting-edge artificial intelligence platform that will revolutionize the way visual effects are created. MARZ AI uses machine learning algorithms to analyze and process large amounts of data, allowing for faster and more accurate rendering of visual effects.
The partnership between MARZ VFX and Vitamin VFX brings together some of the most talented and experienced professionals in the industry. With a combined portfolio that includes work on blockbuster films such as “Avengers: Endgame,” “Game of Thrones,” and “Stranger Things,” MARZ VFX is poised to become a major player in the world of visual effects.
In a statement announcing the merger, MARZ VFX CEO Mark Ford expressed his excitement about the partnership, saying, “We are thrilled to join forces with Vitamin VFX to create a new global excellence partnership. Together, we will be able to offer our clients the highest quality visual effects services while pushing the boundaries of innovation with the launch of MARZ AI.”
The merger between MARZ VFX and Vitamin VFX is a significant development in the world of visual effects, and the launch of MARZ AI promises to revolutionize the industry. With their combined expertise and resources, MARZ VFX is poised to become a leader in the field of visual effects for years to come.